State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Pancreas (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 9.9 with a 95% confidence interval from 9.9 to 10.0 and 41,472 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Louisiana⁷

• Rate : The incidence rate is 11.6 with a 95% confidence interval from 11.2 to 12.0 and 659 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 5)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 11.3 with a 95% confidence interval from 10.9 to 11.7 and 553 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 13)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 11.2 with a 95% confidence interval from 10.9 to 11.5 and 1,330 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 10)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 11.0 with a 95% confidence interval from 9.9 to 12.2 and 74 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 36)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 10.9 with a 95% confidence interval from 10.7 to 11.1 and 2,844 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (2, 14)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 10.8 with a 95% confidence interval from 10.4 to 11.3 and 453 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (1, 22)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 10.8 with a 95% confidence interval from 10.4 to 11.2 and 624 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (2, 21)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 10.8 with a 95% confidence interval from 10.5 to 11.1 and 1,317 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (2, 18)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 10.8 with a 95% confidence interval from 10.5 to 11.0 and 1,965 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (3, 17)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 10.7 with a 95% confidence interval from 10.5 to 11.0 and 1,706 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (3, 19)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 10.7 with a 95% confidence interval from 10.4 to 11.0 and 993 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (3, 21)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 10.7 with a 95% confidence interval from 10.3 to 11.0 and 842 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (3, 21)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 10.6 with a 95% confidence interval from 10.3 to 10.8 and 1,431 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (4, 22)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 10.6 with a 95% confidence interval from 10.3 to 10.8 and 1,405 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (4, 22)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 9.9 to 11.1 and 273 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (2, 31)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 9.7 to 11.3 and 151 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (1, 37)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 10.4 with a 95% confidence interval from 10.1 to 10.7 and 875 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (6, 26)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 10.3 with a 95% confidence interval from 10.0 to 10.6 and 942 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (8, 28)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.4 to 11.1 and 115 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (1, 42)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.5 to 11.0 and 149 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (2, 39)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.6 to 10.8 and 228 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (3, 37)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.7 to 10.6 and 379 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (6, 34)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.9 to 10.4 and 1,590 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (14, 28)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 10.1 with a 95% confidence interval from 9.8 to 10.4 and 812 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (12, 32)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 9.9 with a 95% confidence interval from 9.6 to 10.2 and 762 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (16, 34)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 9.9 with a 95% confidence interval from 9.7 to 10.0 and 3,240 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (20, 31)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.1 to 10.4 and 199 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (8, 43)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 9.7 with a 95% confidence interval from 9.3 to 10.0 and 677 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (20, 39)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.0 to 10.3 and 207 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (11, 45)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 9.2 to 9.8 and 685 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (23, 41)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 8.6 to 10.5 and 90 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (5, 49)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 8.9 to 10.1 and 190 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (15, 46)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.6 to 10.4 and 88 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (6, 49)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 9.3 to 9.6 and 2,849 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (27, 40)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 9.4 with a 95% confidence interval from 8.7 to 10.1 and 143 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (15, 48)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 9.3 with a 95% confidence interval from 9.2 to 9.4 and 4,234 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (30, 41)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.8 to 9.7 and 333 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (23, 47)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.7 to 9.8 and 222 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (21, 48)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.8 to 9.6 and 361 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (26, 46)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.8 to 9.5 and 521 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (28, 46)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.1 to 10.1 and 70 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (12, 51)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.6 to 9.1 and 955 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (36, 47)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.5 to 9.2 and 429 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (32, 48)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.5 to 9.1 and 770 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (36, 48)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.1 to 9.1 and 252 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (35, 50)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.2 to 8.9 and 561 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (39, 49)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 7.6 to 9.6 and 64 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (21, 51)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.2 to 8.8 and 822 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (40, 49)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 8.1 with a 95% confidence interval from 7.8 to 8.4 and 538 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (44, 51)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.4 to 8.2 and 302 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (47, 51)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 7.4 with a 95% confidence interval from 6.9 to 7.9 and 212 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (49, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 5.2 with a 95% confidence interval from 4.9 to 5.5 and 260 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/22/2026 6:38 pm.

State Cancer Registries may provide more current or more local data.



† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

² Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

⁷ Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.